3171 results for «3305»

Filter By

3171 results

The value of WATCHMAN therapy - Who should we treat?

08 Feb 2025 – From PCR Tokyo Valves 2025

Delve into the value of WATCHMAN therapy in this sponsored session by Boston Scientific. Explore the latest evidence and future perspectives of this innovative treatment option. Understand who the ideal patient is for WATCHMAN therapy and how to identify them in daily clinical practice, including TAVI...

The value of WATCHMAN therapy - Who should we treat?

TAV-in-TAV

08 Feb 2025 – From PCR Tokyo Valves 2025

Watch this PCR Tokyo Valves 2025 session on TAV-in-TAV to discover essential insights on optimizing the procedure. Learn how CT analysis and precise measurements are critical for success, and why coronary protection, chimney stenting, and leaflet modification must be considered in high-risk cases. Experts discuss key...

TAV-in-TAV

Mitral valve-in-valve and valve-in-ring electrosurgery

08 Feb 2025 – From PCR Tokyo Valves 2025

Mitral valve-in-valve and valve-in-ring electrosurgery

TAVI complex cases: intravascular hemolysis, Heyde syndrome & more

08 Feb 2025 – From PCR Tokyo Valves 2025

This session presents a diverse array of complex TAVI cases, from interventions for paravalvular leak-induced intravascular hemolysis to cases of severe aortic tortuosity, calcification hindering valve expansion, and successful TAVI in patients with Heyde syndrome and HIV infection. Gain valuable insights into navigating these challenging scenarios.

TAVI complex cases: intravascular hemolysis, Heyde syndrome & more

Future devices for structural heart interventions

08 Feb 2025 – From PCR Tokyo Valves 2025

Get a glimpse into the future of structural heart interventions! This PCR Tokyo Valves 2025 session dives into the latest innovations in imaging and explores groundbreaking devices for mitral and tricuspid valve treatments. Watch as experts discuss how these advancements are set to reshape clinical practice.

Future devices for structural heart interventions

Nightmare in TAVI

08 Feb 2025 – From PCR Tokyo Valves 2025

Watch this session replay featuring two challenging cases: valve embolisation with a balloon-expandable valve and coronary obstruction with a self-expandable valve. Learn key lessons from the first case, including the importance of secure pacing, avoiding damage to the descending aorta while retrieving the embolised valve, and...

Nightmare in TAVI

M-TEER for secondary mitral regurgitation

08 Feb 2025 – From PCR Tokyo Valves 2025

Managing secondary mitral regurgitation with M-TEER requires a tailored approach. This PCR Tokyo Valves 2025 session explores key considerations for atrial functional MR and VFMR beyond COAPT criteria, helping you refine patient selection, procedural strategies, and post-treatment management through expert insights and real-world cases.

M-TEER for secondary mitral regurgitation

Mitral complications

08 Feb 2025 – From PCR Tokyo Valves 2025

Mitral complications

TAVI

08 Feb 2025 – From PCR Tokyo Valves 2025

Dive into this comprehensive TAVI session to explore various techniques and strategies for optimizing procedural outcomes. Discover how to align commissures in self-expandable valves, manage sudden deterioration in severe aortic stenosis without pre-operative evaluation, and tackle the unique challenges of rescue TAVI for cardiogenic shock. Additionally,...

TAVI

Valve-in-valve

08 Feb 2025 – From PCR Tokyo Valves 2025

Explore this comprehensive session on valve-in-valve procedures, covering a wide range of complex scenarios. Gain insights into the first TAVR in a surgically implanted aortic Trifecta valve, TAVI-valve-in-valve double chimney stenting, transcatheter aortic valve replacement in a surgical aortic valve for bioprosthetic valve dysfunction, valve-in-valve for...

Valve-in-valve

Advances in left main bifurcation PCI and renal denervation

06 Oct 2022 – From AICT-ASIAPCR 2022

Discover more about treatment strategies and recent evidence for left main bifurcation, the latest Malaysian Working Group consensus statement on renal denervation, as well as reviewing patient-centred clinical judgement and individualised treatment plans.

Advances in left main bifurcation PCI and renal denervation

Evolving approaches to planning and guiding of complex PCI with ultra-low contrast

06 Oct 2022 – From AICT-ASIAPCR 2022

In this session, presenters describe how to use IVUS and physiology in the assessment of left anterior descending and/or left circumflex ostium in distal left main disease. Discover in the second part the general principles and clinically validated strategies for ultralow contrast coronary angiography and zero...

Evolving approaches to planning and guiding of complex PCI with ultra-low contrast

Beginning with the end in mind - FFR vs. IVUS imaging

06 Oct 2022 – From AICT-ASIAPCR 2022

Consult this session if you want to explore different plaque modification techniques and technology and see how to maximise PCI outcome with IVUS imaging. Also assess when to select FFR to determine when to treat vs. IVUS to determine where and how to treat.

Beginning with the end in mind

Cracking calcium: best practices to integrate intravascular lithotripsy into your calcium management algorithm

07 Oct 2022 – From AICT-ASIAPCR 2022

With this session, keep up to date on the evidence, trials and outcome data for intravascular lithotripsy in severely calcified lesions. Learn how to use this technique in real-world patients and understand its role in the treatment algorithm for severely calcified coronary lesions.

Cracking calcium: best practices to integrate intravascular lithotripsy into your calcium management algorithm

Sirolimus coated balloon: expanding the scope of coronary artery disease treatment

07 Oct 2022 – From AICT-ASIAPCR 2022

Consult this session to understand the technology and scientific evidence of the novel sirolimus drug-coated balloon, to learn its utility for PCI in a variety of lesion and patient subsets and to understand the evidence and outcomes in real-world patients.

Sirolimus coated balloon: expanding the scope of coronary artery disease treatment

Precision PCI - Simplifying the complex - Learn from the masters

07 Oct 2022 – From AICT-ASIAPCR 2022

This session will help you better understand the influence of stent design, drug and polymer on the procedural short and long-term outcomes, the use of OCT in PCI of complex coronary lesions and the role, prevalence and diagnosis of microvascular dysfunction in patients with ischaemia and...

Precision PCI - Simplifying the complex - Learn from the masters

Treatment of small vessel disease - To stent or not to stent?

07 Oct 2022 – From AICT-AsiaPCR 2022

Consult this session if you want to learn the tips and tricks to perform a small vessel disease intervention and to discuss the pros and cons of treating small vessel disease with DCB and/or DES.

Treatment of small vessel disease - To stent or not to stent?

Strategies for successful medical writing

06 Oct 2022 – From AICT-AsiaPCR 2022

What a pleasure to be able to read and re-read one of your own articles once it has been published! Follow this session to get tips and tricks on how to get published and produce quality writing, and to learn how to use all media, including...

Strategies for successful medical writing

Lifetime management of patients with aortic stenosis

06 Oct 2022 – From AICT-AsiaPCR 2022

In this AICT-AsiaPCR 2022 session, review a ViV case to consider coronary occlusion and CT analysis, and examine a TAVI case to discuss failed TAVI bioprosthesis, so as to develop strategies for patients with AS and long-life expectancy.

Lifetime management of patients with aortic stenosis

Duration of DAPT in high bleeding risk and FFR guided PCI vs. CABG for TVD: a guide to interpreting non-inferiority trials

07 Oct 2022 – From AICT-AsiaPCR 2022

Take advantage of this AICT-AsiaPCR 2022 session to learn in detail about the FAME 3 and MASTER-DAPT trials and how to use their results in daily practice, and to better understand what is behind the term "non-inferiority" and when and how to choose a non-inferiority margin.

Duration of DAPT in high bleeding risk and FFR guided PCI vs. CABG for TVD: a guide to interpreting non-inferiority trials
Didn’t find what you were looking for?